Publications authored by CHSPR faculty and staff from 2009 to the present are listed here. Older peer-reviewed publications are usually available from individual journals and can be searched for using PubMed. Older reports published by CHSPR (from 1973) are available from the UBC Library cIRcle database. If you cannot find a specific publication, please contact us.
Greyson DL. Non-biomedical sources for systematic reviews of pharmaceutical policy. J Med Libr Assoc. 2010 Jan;98(1):85-7. Read more
Morgan S, Kennedy J, Boothe K, McMahon M, Roughead E, Watson D. Toward an understanding of high performance pharmaceutical policy systems: a ‘triple-A’ framework and example analysis. Open Health Serv Policy J. 2009;2:1-9. Read more
Morgan S, Hanley G, Greyson D. Comparison of tiered formularies and reference pricing policies: a systematic review. Open Med. 2009;3(3):e131-9. Read more
Law MR, Soumerai SB, Adams AS, Majumdar SR. Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Arch Intern Med. 2009 Nov 23;169(21):1969-74. Read more
Morgan S, Cunningham C, Hanley G, Mooney D. The British Columbia Rx atlas, 2nd edition. Vancouver (BC): UBC Centre for Health Services and Policy Research; Sept 2009. Read more
Morgan S, Hanley G, Raymond C, Blais R. Breadth, Depth and Agreement among Provincial Formularies in Canada. Healthc Policy. 2009 May;4(4):e162-84. Read more
Hanley GE, Morgan SG. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada. Soc Sci Med. 2009 Mar;68(5):919-24. Read more
Evans RG. Old bones, new data: Emmett Hall, private insurance and the defeat of pharmacare. Healthc Policy. 2009 Feb;4(3):16-24. Read more
Law MR, Soumerai SB, Ross-Degnan D, Adams AS. A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. J Clin Psychiatry. 2008 Jan;69(1):47-53. Read more
Morgan S, Raymond C, Mooney D, Martin D. The Canadian Rx atlas, 2nd edition. Vancouver (BC): UBC Centre for Health Services and Policy Research; Dec 2008. Read more
Morgan S. Challenges and changes in pharmacare: could social insurance be the answer? In: Flood CM, Stabile M, Touhy C, editors. Exploring social insurance: can a dose of Europe cure Canadian health care finance? Montreal and Kingston: School of Policy Studies at Queen's U and McGill U; 2008. 199-220. Read more
Morgan S. “Les déterminants des dépenses en médicaments sur ordonnance” (“The determinants of prescription drug expenditure … and what to do about them.”). In: Béland F, Contandriopoulos A-P, Quesnel-Vallée A, Robert L, editors. Le privé dans la santé: un débat sans fin? Montreal: Presse de l'Université de Montréal; 2008. Read more
Morgan S, Lopert R, Greyson D. Toward a definition of pharmaceutical innovation. Open Med. 2008;2(1):e4-7. Read more
Law MR, Majumdar SR, Soumerai SB. Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada:controlled longitudinal study. BMJ. 2008 Sep 2;337:a1055. Read more
Morgan S, McMahon M, Greyson D. "Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia. "Health Policy. 2008 Aug;87(2):133-45. Read more
Morgan S, Mochrie C. Pharmaceutical innovation: can health and economic goals be met? Vancouver (BC): UBC Centre for Health Services and Policy Research; July 2008. Read more
Soumerai SB, Zhang F, Ross-Degnan D, Ball DE, LeCates RF, Law MR, Hughes TE, Chapman D, Adams AS. Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. Health Aff (Millwood). 2008 May-Jun;27(3):w185-95. Read more
Law MR, Ross-Degnan D, Soumerai SB. Effect of prior authorization of second-generation antipsychotic agents on pharmacy utilization and reimbursements. Psychiatr Serv. 2008 May;59(5):540-6. Read more
Morgan SG. The determinants of prescription drug expenditure … and what to do about them. Vancouver (BC): UBC Centre for Health Services and Policy Research; Apr 2008. Read more
Morgan SG, Cunningham C. The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from British Columbia. Healthc Policy. 2008 Feb;3(3):54-63. Read more